Bioamber (BIOA) Receiving Somewhat Favorable Media Coverage, Study Shows

News coverage about Bioamber (NYSE:BIOA) has been trending somewhat positive recently, according to Accern Sentiment Analysis. The research firm identifies negative and positive news coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Bioamber earned a news sentiment score of 0.17 on Accern’s scale. Accern also gave news headlines about the biotechnology company an impact score of 47.3833869937947 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

Here are some of the news headlines that may have effected Accern Sentiment’s analysis:

A number of research firms recently issued reports on BIOA. ValuEngine cut shares of Bioamber from a “hold” rating to a “sell” rating in a research note on Thursday, March 1st. Zacks Investment Research raised shares of Bioamber from a “sell” rating to a “hold” rating in a research note on Monday, February 19th.

Shares of Bioamber (NYSE BIOA) traded down $0.01 on Friday, reaching $0.05. 4,433,180 shares of the company’s stock traded hands, compared to its average volume of 3,408,292. Bioamber has a 52 week low of $0.04 and a 52 week high of $2.90. The company has a debt-to-equity ratio of 0.24, a quick ratio of 0.75 and a current ratio of 1.08. The firm has a market cap of $3.08, a PE ratio of -0.07 and a beta of 3.29.

COPYRIGHT VIOLATION WARNING: This story was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this story on another site, it was stolen and reposted in violation of US & international copyright legislation. The original version of this story can be read at

About Bioamber

BioAmber Inc (BioAmber), formerly DNP Green Technology, Inc, is an industrial biotechnology company, which produces sustainable chemicals. The Company’s technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstocks into sustainable chemicals that are replacements for petroleum-derived chemicals, which are used in a range of everyday products, including plastics, food additives and personal care products.

Insider Buying and Selling by Quarter for Bioamber (NYSE:BIOA)

Receive News & Ratings for Bioamber Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioamber and related companies with's FREE daily email newsletter.

Leave a Reply